Khanthachai C / Shutterstock.com

29 April 2025NewsAmericasSarah Speight

Why US patent reform is ‘essential’ for US economic prosperity and security

Proposed patent legislation will save US innovation and counter the ‘existential threat’ that China poses to the West, hears Sarah Speight.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Strategic IP protection for biotech-related GenAI

24 April 2025 Generative AI is transforming the biotech industry, so it’s crucial to have an IP strategy—in particular, for trade secret and/or patent protection. Dean Pelletier of Pelletier Law explains.

How pharma should prep for the six-bill avalanche from Congress

17 April 2025 The bipartisan legislative push could create big hurdles for drug development, with concerns mounting over limited patent protections and increased litigation risks, hears Marisa Woutersen.

EPO: Biotech innovation strong, while pharma trails behind

8 April 2025 According to the Patent Index 2024, patent filings remained high in Europe last year “despite political and economic uncertainties” | Johnson & Johnson ranked among the top requesters of unitary patents.

More on this story

Strategic IP protection for biotech-related GenAI

24 April 2025 Generative AI is transforming the biotech industry, so it’s crucial to have an IP strategy—in particular, for trade secret and/or patent protection. Dean Pelletier of Pelletier Law explains.

How pharma should prep for the six-bill avalanche from Congress

17 April 2025 The bipartisan legislative push could create big hurdles for drug development, with concerns mounting over limited patent protections and increased litigation risks, hears Marisa Woutersen.

EPO: Biotech innovation strong, while pharma trails behind

8 April 2025 According to the Patent Index 2024, patent filings remained high in Europe last year “despite political and economic uncertainties” | Johnson & Johnson ranked among the top requesters of unitary patents.

More on this story

Strategic IP protection for biotech-related GenAI

24 April 2025 Generative AI is transforming the biotech industry, so it’s crucial to have an IP strategy—in particular, for trade secret and/or patent protection. Dean Pelletier of Pelletier Law explains.

How pharma should prep for the six-bill avalanche from Congress

17 April 2025 The bipartisan legislative push could create big hurdles for drug development, with concerns mounting over limited patent protections and increased litigation risks, hears Marisa Woutersen.

EPO: Biotech innovation strong, while pharma trails behind

8 April 2025 According to the Patent Index 2024, patent filings remained high in Europe last year “despite political and economic uncertainties” | Johnson & Johnson ranked among the top requesters of unitary patents.

More features

Commercialising genomic tech in Nigeria

Medical company sees $452m trade secrets award cut by 87%

Fed Circ: Generic doesn’t infringe Metacel MS drug

Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO

WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025

Strategic IP protection for biotech-related GenAI

South Korean firm sues in UK over CRISPR/Cas9 blood disorder drug

In vivo cell therapy: A world beyond ex vivo engineering